Does gut immune activity regulate tryptophan metabolism and shift it toward quinolinic acid during inflammation?

Tryptophan metabolism represents a critical physiological junction where the gut microbiota and host immune system interact to dictate the balance between peripheral neurotransmission and systemic inflammation.

Microbiota and immune regulation

• The Serotonin Pathway: Under homeostatic conditions, the gut microbiota promotes serotonin synthesis. Commensal bacteria (such as Lactobacillus) ferment dietary fiber to produce short-chain fatty acids (SCFAs), particularly acetate. These SCFAs bind to FFAR3 receptors on enterochromaffin cells, upregulating tryptophan hydroxylase 1 (TPH1) transcription to drive serotonin production.
• The Immune Switch: Mucosal immune activation, triggered by lipopolysaccharides (LPS) via Toll-like receptors (TLRs) or pro-inflammatory cytokines like TNF-alpha and interferon-gamma (IFN-γ), acts as a molecular switch. This inflammatory milieu strongly upregulates indoleamine 2,3-dioxygenase 1 (IDO1), diverting tryptophan flux away from serotonin and into the kynurenine pathway.

Inflammatory shunt to quinolinic acid

• Enzymatic Cascade: Chronic or acute inflammation not only induces IDO1 but also upregulates downstream kynurenine 3-monooxygenase (KMO). KMO converts kynurenine to 3-hydroxykynurenine, committing metabolic intermediates to the neurotoxic arm of the pathway.
• Neurotoxic Endproducts: Subsequent metabolism by 3-hydroxyanthranilate 3,4-dioxygenase (3-HAO) generates quinolinic acid, a potent NMDA receptor agonist and pro-oxidant. This pathway shift decreases the protective kynurenic acid-to-quinolinic acid ratio, contributing to neuroinflammation and cellular stress—a cascade highly relevant to age-related inflammatory and neurodegenerative pathologies.

Bottom line

• Tryptophan fate is dynamically controlled by a biological balance: gut microbiota-derived SCFAs favor serotonin synthesis via TPH1, whereas inflammatory cytokines upregulate IDO1 and KMO to shift metabolism toward the neurotoxic, pro-oxidant pathway culminating in quinolinic acid.